Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Hysterectomy and Levonorgestrel-releasing IUS in the Treatment of Menorrhagia

Trial Profile

Hysterectomy and Levonorgestrel-releasing IUS in the Treatment of Menorrhagia

Status: Completed
Phase of Trial: Phase III

Latest Information Update: 05 Mar 2020

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Levonorgestrel (Primary)
  • Indications Menorrhagia
  • Focus Biomarker; Therapeutic Use
  • Acronyms VUOKKO

Most Recent Events

  • 12 Jun 2011 Ten-year follow-up results assessing the effect of treatment on serum inflammatory marker levels presented at the 13th World Congress on Menopause.
  • 15 Feb 2010 Results published in BJOG: An International Journal of Obstetrics and Gynaecology.
  • 26 Dec 2009 Results were published in Acta Obstetricia et Gynecologica Scandinavica.

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top